US federal science policy realignment: Silicon Valley’s corporate capture reshapes R&D priorities, undermining public-interest innovation ecosystems
Original framing: “Trump’s ‘golden age’ push hands top science honours to big tech. Will it work?” — South China Morning Post
Scenario planning for the next decade suggests that if current trends continue, the ‘golden age’ narrative will accelerate the hollowing out of federally funded basic research, leading to a two-tiered innovation system: one for proprietary, high-impact discoveries (e.g., AI, gene editing) controlled by tech oligarchs, and another for applied, low-risk research in universities and national labs. Models like the *MIT Technology Review’s* ‘Techno-Oligarchy’ scenario predict that by 2035, the top 10 tech firms will control 80% of global R&D spending, further concentrating power in the hands of a techno-meritocratic elite. The *World Economic Forum’s* *Future of Jobs Report* (2023) warns that this will exacerbate inequality in access to scientific knowledge, as proprietary models limit open-source collaboration. Conversely, the *UN’s Sustainable Development Goals* framework suggests that a more equitable model—such as the *Brazilian* *Fundo de Tecnologia* (tech fund) or the *EU’s* *Horizon Europe*—could prioritize inclusive innovation. The framing’s focus on ‘will it work?’ ignores these divergent futures and the structural choices that will determine which path is taken.
Text: The US’s ‘golden age’ of science is not a spontaneous resurgence of innovation but a deliberate realignment of federal policy to serve the interests of techno-meritocratic elites, where billionaire-aligned awards like the National Medal of Science function as symbolic capital to legitimize corporate capture.
This shift mirrors historical patterns of elite capture—from the *Gilded Age* railroad barons to the post-WWII military-industrial complex—yet today it is framed as a neutral celebration of ‘disruptive innovation,’ obscuring how proprietary models stifle collaboration and delay societal benefits. The framing’s silence on marginalized voices—such as postdocs exploited by precarious funding or Indigenous scientists whose knowledge is co-opted—reveals a narrative that treats science as a zero-sum competition rather than a collective endeavor. Cross-cultural perspectives, from Germany’s *Forschungsgemeinschaft* to Brazil’s *Fundo de Tecnologia*, offer viable alternatives where academic autonomy and public service are legally protected, yet these are absent from the ‘golden age’ discourse. The trickster reading exposes this as a mythic trope, where the ‘golden age’ is less a return to past glory and more a *feast of fools* where billionaires dine on public resources while the public pays the bill. Future modelling suggests that without systemic reforms—such as reinstating federal funding for basic research or adopting the EU’s open science framework—the US risks a two-tiered innovation system, where proprietary breakthroughs are hoarded by tech oligarchs while the public is left with applied, low-risk research. The synthesis of these dimensions reveals that the ‘golden age’ narrative is not about science but about power: it is a strategic repackaging of corporate governance as progress, where the real ‘gold’ is being mined from public resources and handed to private hands under the guise of meritocracy.